Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Neugebauer

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2007
Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancerS Boeck, T Hoehler, G Seipelt, et al.
Lancet Regional Health. Americas|May 15, 2024
Race and ethnicity and pharmacy dispensing of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetesLuis A Rodriguez, Holly Finertie, Romain S Neugebauer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2015
Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML--long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL)A Thiel, J Schetelig, W Pönisch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 25, 2024
Brief Report: Protease Inhibitors Versus Nonnucleoside Reverse Transcriptase Inhibitors and the Risk of Cancer Among People With HIVSally B Coburn, Noel Pimentel, Wendy Leyden, et al.
Diabetes, Obesity & Metabolism|January 2, 2026
Comparative safety of glucose-lowering medications on depression in adults with type 2 diabetesStephanie A Hooker, Romain S Neugebauer, Julie A Schmittdiel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 18, 2018
Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and CanadaElizabeth L Yanik, Raúl U Hernández-Ramírez, Li Qin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2019
Association of Immunosuppression and Human Immunodeficiency Virus (HIV) Viremia With Anal Cancer Risk in Persons Living With HIV in the United States and CanadaRaúl U Hernández-Ramírez, Li Qin, Haiqun Lin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 11, 2017
Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and CanadaRobert Dubrow, Li Qin, Haiqun Lin, et al.
The Lancet. HIV|March 4, 2019
Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort studyRaúl U Hernández-Ramírez, Li Qin, Haiqun Lin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2020
Timing of Antiretroviral Therapy Initiation and Risk of Cancer Among Persons Living With Human Immunodeficiency VirusMichael J Silverberg, Wendy Leyden, Raúl U Hernández-Ramírez, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2007
Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancerS Boeck, T Hoehler, G Seipelt, et al.
Lancet Regional Health. Americas|May 15, 2024
Race and ethnicity and pharmacy dispensing of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetesLuis A Rodriguez, Holly Finertie, Romain S Neugebauer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2015
Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML--long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL)A Thiel, J Schetelig, W Pönisch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 25, 2024
Brief Report: Protease Inhibitors Versus Nonnucleoside Reverse Transcriptase Inhibitors and the Risk of Cancer Among People With HIVSally B Coburn, Noel Pimentel, Wendy Leyden, et al.
Diabetes, Obesity & Metabolism|January 2, 2026
Comparative safety of glucose-lowering medications on depression in adults with type 2 diabetesStephanie A Hooker, Romain S Neugebauer, Julie A Schmittdiel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 18, 2018
Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and CanadaElizabeth L Yanik, Raúl U Hernández-Ramírez, Li Qin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2019
Association of Immunosuppression and Human Immunodeficiency Virus (HIV) Viremia With Anal Cancer Risk in Persons Living With HIV in the United States and CanadaRaúl U Hernández-Ramírez, Li Qin, Haiqun Lin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 11, 2017
Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and CanadaRobert Dubrow, Li Qin, Haiqun Lin, et al.
The Lancet. HIV|March 4, 2019
Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort studyRaúl U Hernández-Ramírez, Li Qin, Haiqun Lin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2020
Timing of Antiretroviral Therapy Initiation and Risk of Cancer Among Persons Living With Human Immunodeficiency VirusMichael J Silverberg, Wendy Leyden, Raúl U Hernández-Ramírez, et al.
Pageof 5